Imperial College London Featured PhD Programmes
University College London Featured PhD Programmes
University of Exeter Featured PhD Programmes
University of Edinburgh Featured PhD Programmes
Cardiff University Featured PhD Programmes
"science" AND "communicat…×
10 miles

Cell Biology / Development (science communication) PhD Projects, Programs & Scholarships

We have 97 Cell Biology / Development (science communication) PhD Projects, Programs & Scholarships

  • "science" AND "communication" ×
  • Cell Biology / Development×
  • clear all
Order by 
Showing 1 to 10 of 97
  The role and regulation of microtubules during axon growth and degeneration
  Prof A Prokop
Applications accepted all year round

Funding Type

PhD Type

Axons are the enormously long cable-like processes of neurons that wire the nervous system. These delicate structures have to be maintained for a life time.
  MRC DiMeN Doctoral Training Partnership: Liquid biopsy of the liver to improve molecular targeted cancer therapy
  Prof C Goldring, Prof F Falciani, Dr A Chadwick, Dr M Cross
Application Deadline: 6 January 2020

Funding Type

PhD Type

Molecular targeted therapies have revolutionised oncology. However, whilst patient life-expectancy is improving, these therapies carry a risk of causing damage to healthy tissues in the body, especially to the liver.
  MRC DiMeN Doctoral Training Partnership: Developing protein tools to target DNA damage response and repair in cancer cells
  Dr Q. Wu, Dr D Tomlinson
Application Deadline: 6 January 2020

Funding Type

PhD Type

DNA damage response (DDR) and repair play critical roles in influencing the efficiency and sensitivity of many cancer treatments.
  MRC DiMeN Doctoral Training Partnership: Cell cycle regulation in oocytes: can we prevent chromosome division errors that result in infertility and miscarriage?
  Dr S Madgwick, Prof J Higgins
Application Deadline: 6 January 2020

Funding Type

PhD Type

We are pleased to invite candidates to apply for our PhD studentship investigating the role of cell cycle protein regulation in preventing cell division errors that lead to infertility and miscarriage in women.
  MRC DiMeN Doctoral Training Partnership: RNA modifications: cracking the RNA code in health and disease
  Prof K Stellos, Prof I Spyridopoulos, Dr A Gatsiou, Dr S Tual-Chalot
Application Deadline: 6 January 2020

Funding Type

PhD Type

Inflammation comprises a fundamental biological process tasked to protect our body against invasion of microorganisms (e.g virus, bacteria, etc).
  Symbiosis in a changing environment – what is the future of the lichen?
  Dr C Colesie, Dr S Hennige
Application Deadline: 9 January 2020

Funding Type

PhD Type

Summary. Global warming can disrupt symbiotic relationships, leading to wide-scale ecosystem failures, such as coral bleaching. This project assesses analogue processes in the terrestrial realm, studying a key vegetation component – lichens.
  MRC DiMeN Doctoral Training Partnership: Targeting cancer through disruption of the ubiquitin economy
  Prof M Clague, Prof S Urbé
Application Deadline: 6 January 2020

Funding Type

PhD Type

A PhD project in the shared laboratory of Prof. Michael Clague and Prof. Sylvie Urbé http://pcwww.liv.ac.uk/~clague/ in collaboration with an industry partner.
  MRC DiMeN Doctoral Training Partnership: How do non-coding enhancer RNAs confer genetic risk in Amyotrophic Lateral Sclerosis (ALS)?
  Dr Dan Bose, Dr J Cooper-Knock
Application Deadline: 6 January 2020

Funding Type

PhD Type

Project. Amyotrophic Lateral Sclerosis (ALS) is an aggressive neurodegenerative disease with no effective therapy. The established genetic causes of ALS can only explain a small fraction of the observed disease phenotypes.
  MRC DiMeN Doctoral Training Partnership: How do non-coding enhancer RNAs confer genetic risk in Amyotrophic Lateral Sclerosis (ALS)?
  Dr Dan Bose, Dr J Cooper-Knock
Application Deadline: 6 January 2020

Funding Type

PhD Type

Project. Amyotrophic Lateral Sclerosis (ALS) is an aggressive neurodegenerative disease with no effective therapy. The established genetic causes of ALS can only explain a small fraction of the observed disease phenotypes.
  MRC DiMeN Doctoral Training Partnership: Investigating the in vivo targets and mechanism of action of a toxic acetylcholinesterase-derived peptide upregulated in Alzheimer’s disease
  Dr M Collins, Prof S Greenfield
Application Deadline: 6 January 2020

Funding Type

PhD Type

Alzheimer’s disease (AD) is a progressive neurodegenerative disease that is characterised by the deposition and accumulation of amyloid beta plaques and phosphorylated tau filaments in the brain, the latter correlating with the onset of symptoms.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.